Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Insulin Resistance and Metabolic Comorbidities in Alzheimer’s Disease

View ORCID ProfileMartina Johansson
doi: https://doi.org/10.1101/2021.04.23.21255980
Martina Johansson
1Department of Health, Medicine & Caring Sciences, Linköping University, 58185 Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martina Johansson
  • For correspondence: martina.akj@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Alzheimer’s disease affects 50 million people worldwide and just like any modern lifestyle disease, it is steadily increasing. Unfortunately, a cure has not yet been found, despite decades of research. The pathophysiology of Alzheimer’s disease is extraordinarily complex and involves many different factors. Despite it being a protein misfolding disease, a lot of evidence currently point to insulin resistance, impaired glucose metabolism and comorbidities with other metabolic disorders such as obesity, elevated blood lipids, and non-alcoholic fatty liver disease, as a potential root cause. Genetics aside, it seems like poor metabolic functioning affects the brain and central nervous system a great deal: affecting mood, behaviour, and cognitive performance. Even mood disorders are interlinked with metabolic disorders and increase the risk for Alzheimer’s disease later in life. This is a summary of objectively chosen original research articles, published between 2011-2021 and with insulin resistance as the main objective for cognitive impairment and Alzheimer’s disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received for this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

N/A

  • Abbreviations

    AD
    Alzheimer’s Disease
    Aβ
    Amyloid beta
    APP
    Amyloid beta precursor protein
    CBF
    Cerebrospinal blood flow
    CSF
    Cerebrospinal spinal fluid
    CI
    Cognitive impairment
    HPA
    Hypothalamus, Pituitary, Adrenal
    HOMA-IR
    Homeostatic model for insulin resistance
    IGF-1
    Insulin growth factor 1
    IR
    Insulin resistance
    MCI
    Major cognitive impairment
    MDD
    Major depressive disorder
    NAFLD
    Non-alcoholic fatty liver disease
    SSPG
    Steady-state plasma glucose
    T2DM
    Type 2 Diabetes Mellitus
    T1D
    Type 1 Diabetes
    TNF-α
    Tumor necrosis factor alpha
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 25, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Insulin Resistance and Metabolic Comorbidities in Alzheimer’s Disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Insulin Resistance and Metabolic Comorbidities in Alzheimer’s Disease
    Martina Johansson
    medRxiv 2021.04.23.21255980; doi: https://doi.org/10.1101/2021.04.23.21255980
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Insulin Resistance and Metabolic Comorbidities in Alzheimer’s Disease
    Martina Johansson
    medRxiv 2021.04.23.21255980; doi: https://doi.org/10.1101/2021.04.23.21255980

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1095)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
    • Epidemiology (9764)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2304)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1555)
    • Health Policy (734)
    • Health Systems and Quality Improvement (603)
    • Hematology (236)
    • HIV/AIDS (503)
    • Infectious Diseases (except HIV/AIDS) (11637)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (237)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2140)
    • Nursing (134)
    • Nutrition (336)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1174)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (310)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (299)
    • Primary Care Research (266)
    • Psychiatry and Clinical Psychology (2179)
    • Public and Global Health (4653)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (210)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)